Skip to main content
. 2014 May-Jun;8(5-6):175–180. doi: 10.5489/cuaj.1362

Fig. 1.

Fig. 1.

Algorithm for decision making for introduction of a second anticholinergic. 1If oxybutinin ER was not well tolerated, it was discontinued and changed for Tolterodine ER 4 mg. 2Suboptimal response: based on clinical and/or urodynamic study criteria. 3Introduction of the second anticholinergic medication. 4If tolterodine ER 4 mg was not well tolerated as a second anticholinergic medication, it was discontinued and changed for solifenacin 5 mg. 5If solifenacin was not well-tolerated, it was discontinued and alternative treatment was offered. ⊕ Addition of medication; Inline graphic: change of medication.